SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026025
Filing Date
2021-05-10
Accepted
2021-05-10 16:01:27
Documents
59
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-10q_20210331.htm   iXBRL 10-Q 2521469
2 EX-31.1 enta-ex311_7.htm EX-31.1 16040
3 EX-31.2 enta-ex312_8.htm EX-31.2 16026
4 EX-32.1 enta-ex321_6.htm EX-32.1 8764
5 GRAPHIC g05my3l5gj1l000001.jpg GRAPHIC 114355
  Complete submission text file 0001564590-21-026025.txt   8246431

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20210331.xsd EX-101.SCH 33916
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20210331_cal.xml EX-101.CAL 43939
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20210331_def.xml EX-101.DEF 105451
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20210331_lab.xml EX-101.LAB 303125
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20210331_pre.xml EX-101.PRE 245212
11 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20210331_htm.xml XML 1686290
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 21906962
SIC: 2834 Pharmaceutical Preparations